Evaluation of cord bilirubin and hemoglobin analysis in predicting pathological jaundice in term babies at risk of ABO incompatibility

Elango Krishnan, Raja Periasamy, Sathiya Priya Sekar


Background: Cord bilirubin and hemoglobin analysis helps not only in predicting the pathological jaundice in ABO incompatibility but also useful for early referral and intervention for better outcome. Aim of this study is to evaluate the cord blood bilirubin and hemoglobin analysis in predicting pathological hyperbilirubinemia in newborn at risk of ABO incompatibility.

Methods: In this descriptive study conducted in Government Stanley medical college between January 2016-June 2016, A positive or B positive babies born to O positive mothers with birth weight >2.5 kgs and gestational age >37 weeks were included. A total of 191 babies were studied. Cord bilirubin, reticulocyte count, hemoglobin and fourth day bilirubin were evaluated and data was analysed using Pearson’s Chi square and ANOVA.

Results: Out of 191 babies, 25 (13%) did not develop any jaundice, 122 (64%) developed physiological jaundice and 44 (23%) had pathological jaundice. The mean cord bilirubin and cord hemoglobin values of newborn who did not develop jaundice were 1.35mg/dl and 15.3g/dl while the values among pathological jaundice were 3.15mg/dl and 14.97g/dl. 

Conclusions: Babies with cord bilirubin >1.8mg/dl and hemoglobin <15.1gm/dl are more prone for pathological hyperbilirubinemia.


ABO incompatibility, Jaundice, Cord bilirubin

Full Text:



Madan A, MacMahon JR, David K. Stevenson. Neonatal hyperbilirubinemia. Avery’s disease of the newborn. 8th edition. 1226-56.

Cloherty JP, Eichenwald EC, Hansen AR, Ann R. Neonatal hyperbilirubinemia. Stark’s manual of Neonatal care 7th edition. 304-39.

Liu LL, Clemens CJ, Shay DK, Davis RL, Novack AH. The safety of newborn early discharge: the Washington state experience. JAMA. 1997;278;293-8.

Kornacka RJ, Kerman ME. Usefulness of measuring bilirubin levels in cord bllod for predicting hyperbilirubinemia in newborns. Ginekol Pol. 1994;65(6)276-80.

Johnstone JM. Department of Pathology, Isleworth. Bilirubin values of cord blood in heterospecific pregnancy. ClinPathol. 1953;6(3);215-8.

Orzalesi M, Gloria F, Lucarelli P, Bottini E. Relationship between direct Coomb’s test positivity and neonatal jaundice. Paediatrics 1973;51;288-9.

Han P, Kiruba R, Ong R, Joseph R, Tan KL, Wong HB. Hemolytic disease due to ABO incompatibility incidence and value of screening in an Asian population. Aust Paediatr J. 1988;24(1);35-8.

Whyte J, Graham H. Prediction of the severity of ABO hemolytic disease of the newborn by cord blood tests. Acta Paediatri Scand. 1981;70;217-22.

Chen JY, Ling UP. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. 1994;53(1);13-8.

Procianoy RS1, Giacomini CB, Farina DM, Mollin GA, Winckler MI, Silveira MB, et al. Early diagnosis of ABO haemolytic disease of the newborn. 1987;146(4);390-3.